Criterios de bajo riesgo de mortalidad en niños con neutropenia y fiebre durante la quimioterapia por cáncer. / [Criteria of low risk of mortality in children with neutropenia and fever during cancer chemotherapy]
Medicina [B Aires]
; 61(1): 63-6, 2001.
Artigo
em Espanhol
| BINACIS
| ID: bin-39574
Biblioteca responsável:
AR2.1
ABSTRACT
To validate the use of a lower-risk mortality profile in pediatric febrile neutropenia during anticancer therapy and to evaluate the efficacy of a sequential parenteral-oral antibiotic treatment for these children, a prospective study was conducted between May 1997 and December 1999. During this period 247 episodes in 215 patients were included in the present study. Children with neutropenia (ANC < 500/mm3) and fever (> 38 degrees C) due to anticancer therapy were eligible for the study if they presented the following lower-risk conditions absence of severe co-morbidity factors, good clinical condition, no risk clinical foci, no bacteremia, and responsible parents. They were initially treated with inpatient parenteral short course of ceftriaxone and amikacin followed by ambulatory oral cefixime or ciprofloxacin to complete 7 days. Mean age was 64 (range 8-200) months. The most common underlying malignant disease was acute lymphoblastic leukemia in 48
Buscar no Google
Coleções:
Bases de dados nacionais
/
Argentina
Base de dados:
BINACIS
Tipo de estudo:
Estudo de etiologia
/
Estudo observacional
Idioma:
Espanhol
Revista:
Medicina [B Aires]
Ano de publicação:
2001
Tipo de documento:
Artigo